Loading…
Chemcon Speciality Chemicals (CHEMCON)₹195.35+0.10%Specialty Chemicals
In the Jun 2026 quarter (standalone), Chemcon Speciality Chemicals reported sales of ₹66.18 Cr, up 22.2% from Jun 2025, and net profit of ₹10.99 Cr, up 83.5% year on year. For the year to Mar 2026, sales were ₹241 Cr and net profit ₹23.95 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 75.22 | 53.15 | 60.21 | 46.14 | 53.16 | 54.14 | 55.14 | 54.17 | 54.17 | 57.18 | 75.18 | 66.18 |
| Expenses | 66.77 | 46.87 | 54.86 | 37.91 | 43.87 | 42.90 | 48.88 | 45.91 | 46.85 | 50.85 | 66.77 | 50.85 |
| Operating Profit | 7.98 | 5.98 | 3.99 | 6.99 | 8.97 | 10.97 | 5.98 | 7.98 | 6.98 | 6.99 | 8.97 | 14.97 |
| OPM % | 10.9% | 11.9% | 7.0% | 15.9% | 15.9% | 21.0% | 11.0% | 15.0% | 12.9% | 11.9% | 11.9% | 23.0% |
| Other Income | 3.01 | 3.01 | 3.01 | 4.02 | 4.02 | 4.02 | 3.01 | 4.02 | 4.01 | 4.02 | 4.02 | 4.02 |
| Interest | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 |
| Depreciation | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 3.99 |
| Profit before tax | 8.01 | 6.01 | 4.01 | 7.01 | 9.01 | 12.01 | 5.01 | 8.01 | 8.01 | 7.01 | 9.01 | 15.01 |
| Tax % | 26.0% | 27.0% | 30.0% | 27.0% | 26.0% | 26.0% | 27.0% | 24.0% | 28.0% | 25.0% | 28.0% | 25.0% |
| Net Profit | 5.99 | 3.99 | 2.99 | 4.99 | 5.99 | 8.98 | 3.99 | 5.99 | 5.99 | 4.99 | 5.99 | 10.99 |
| EPS (Rs) | 1.63 | 1.22 | 0.80 | 1.48 | 1.74 | 2.42 | 1.09 | 1.75 | 1.58 | 1.40 | 1.75 | 3.00 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 97.23 | 88.22 | 158 | 304 | 263 | 244 | 258 | 304 | 268 | 208 | 241 | 253 |
| Expenses | 86.82 | 78.81 | 112 | 236 | 192 | 161 | 175 | 232 | 239 | 174 | 209 | 215 |
| Operating Profit | 9.97 | 8.98 | 45.86 | 65.79 | 69.88 | 80.85 | 81.79 | 70.84 | 26.92 | 32.92 | 29.92 | 37.91 |
| OPM % | 9.9% | 10.0% | 28.9% | 21.9% | 26.9% | 32.9% | 31.9% | 23.0% | 10.0% | 16.0% | 12.9% | 15.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 2.01 | 4.01 | 5.02 | 9.03 | 13.05 | 13.05 | 14.05 | 15.06 | 16.07 |
| Interest | 3.01 | 2.01 | 3.01 | 4.01 | 5.01 | 4.01 | 1.01 | 1.01 | 4.01 | 3.01 | 2.01 | 3.03 |
| Depreciation | 1.99 | 1.99 | 1.99 | 2.99 | 4.99 | 5.98 | 5.98 | 7.97 | 9.97 | 10.96 | 11.96 | 12.96 |
| Profit before tax | 5.01 | 5.01 | 41.04 | 61.12 | 65.14 | 76.06 | 84.18 | 74.11 | 26.04 | 33.05 | 32.05 | 39.04 |
| Tax % | 35.0% | 37.0% | 35.0% | 30.0% | 25.0% | 26.0% | 25.0% | 26.0% | 27.0% | 26.0% | 26.0% | — |
| Exceptional items | −0.01 | 0.00 | 0.03 | −0.03 | −0.03 | −0.03 | −0.22 | 0.48 | 0.01 | 0.01 | 0.00 | — |
| Net Profit | 2.99 | 2.99 | 25.95 | 42.94 | 48.89 | 55.87 | 62.90 | 54.89 | 18.96 | 23.95 | 23.95 | 27.96 |
| EPS (Rs) | 4.10 | 3.79 | 33.29 | 13.57 | 15.41 | 15.43 | 17.16 | 15.07 | 5.26 | 6.68 | 6.45 | 7.73 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 26.9% | 0.0% | 0.0% | 100.9% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.01 | 8.01 | 8.01 | 8.01 | 32.03 | 32.03 | 37.12 | 37.09 | 37.10 | 37.10 | 37.10 | 37.08 |
| Reserves | 12.95 | 15.95 | 18.92 | 45.83 | 64.76 | 115 | 317 | 381 | 421 | 440 | 464 | 447 |
| Borrowings | 12.04 | 13.05 | 20.08 | 17.06 | 33.13 | 46.20 | 6.02 | 36.17 | 64.29 | 43.17 | 25.10 | 53.21 |
| Other Liabilities | 10.04 | 8.99 | 15.04 | 27.13 | 43.21 | 34.17 | 44.21 | 45.21 | 32.15 | 26.13 | 29.14 | 32.15 |
| Total Liabilities | 44.04 | 46.00 | 63.05 | 97.03 | 173 | 226 | 404 | 499 | 554 | 546 | 554 | 569 |
| Fixed Assets | 19.99 | 18.97 | 23.99 | 29.95 | 39.98 | 48.97 | 66.90 | 81.93 | 141 | 146 | 149 | 195 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 4.01 | 9.02 | 34.10 | 14.03 | 42.13 | 40.13 | 21.06 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.01 | 10.01 |
| Other Assets | 24.05 | 27.03 | 38.06 | 67.08 | 133 | 173 | 329 | 383 | 399 | 356 | 355 | 343 |
| Inventories | 7.99 | 7.99 | 8.99 | 20.99 | 45.95 | 47.96 | 58.96 | 34.97 | 78.92 | 61.93 | 85.96 | 66.96 |
| Trade receivables | 9.01 | 13.01 | 22.02 | 30.01 | 64.05 | 89.05 | 95.03 | 102 | 68.11 | 82.14 | 52.02 | 64.10 |
| Cash & equivalents | 1.01 | 0.99 | 0.99 | 1.01 | 12.01 | 13.99 | 122 | 224 | 131 | 171 | 142 | 189 |
| Total Assets | 44.04 | 46.00 | 63.05 | 97.03 | 173 | 226 | 404 | 499 | 554 | 546 | 554 | 569 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 7.01 | 4.99 | 10.01 | 14.01 | 11.01 | 12.01 | 64.96 | 74.03 | 12.99 | 11.99 | 41.01 | 41.97 |
| Cash from investing activity | −5.01 | −2.01 | −9.01 | −7.01 | −24.01 | −16.02 | −152 | −91.99 | −16.01 | −25.01 | −19.01 | −35.04 |
| Cash from financing activity | −3.01 | −3.01 | −2.01 | −6.01 | 12.01 | 4.01 | 111 | 30.02 | 12.01 | −25.04 | −22.04 | −3.01 |
| Net cash flow | −1.01 | 0.00 | −1.01 | 1.01 | 0.00 | 0.00 | 23.02 | 11.01 | 8.99 | −37.03 | 0.00 | 3.01 |
| Capex | 3.58 | 1.31 | 7.85 | 8.09 | 14.31 | 15.66 | 31.95 | 50.27 | 46.31 | 42.94 | 9.60 | 9.22 |
| Free cash flow | 3.01 | 3.01 | 2.01 | 7.02 | −2.01 | −2.01 | 34.11 | 24.09 | −32.08 | −31.08 | 31.08 | 32.11 |
| CFO / OP % | 105.0% | 65.0% | 130.1% | 62.0% | 51.1% | 41.1% | 99.0% | 119.1% | 49.0% | 78.1% | 131.0% | 163.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 53 | 52 | 94 | 69 | 78 | 125 | 143 | 147 | 82 | 113 | 92 | 98 |
| Inventory days | 74 | 45 | 58 | 99 | 91 | 118 | 175 | 102 | 164 | 119 | 261 | 158 |
| Days payable | 78 | 38 | 80 | 81 | 56 | 62 | 66 | 69 | 43 | 22 | 48 | 41 |
| Cash conversion cycle | 47 | 57 | 70 | 86 | 111 | 179 | 250 | 177 | 201 | 208 | 303 | 212 |
| Working capital days | 64 | 59 | 8 | 61 | 59 | 135 | 184 | 105 | 108 | 162 | 211 | 120 |
| ROCE % | 17.0% | 22.1% | 16.0% | 74.0% | 65.0% | 43.1% | 29.0% | 21.1% | 15.0% | 6.0% | 7.0% | 6.0% |
For the Jun 2026 quarter, Chemcon Speciality Chemicals reported sales of ₹66.18 Cr, up 22.2% year on year and net profit of ₹10.99 Cr, up 83.5% year on year. The operating margin was 23.0%.
Chemcon Speciality Chemicals' sales for the year to Mar 2026 were ₹241 Cr; over the last twelve months they were ₹253 Cr.
Net profit for the year to Mar 2026 was ₹23.95 Cr, and ₹27.96 Cr over the last twelve months. Earnings per share over the same trailing period were ₹7.73.
Chemcon Speciality Chemicals reported borrowings of ₹53.21 Cr at Mar 2026, against cash and equivalents of ₹189 Cr.
Cash from operations was ₹41.97 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹32.11 Cr.